Your browser doesn't support javascript.
loading
A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults.
Thase, Michael E; Mahableshwarkar, Atul R; Dragheim, Marianne; Loft, Henrik; Vieta, Eduard.
Affiliation
  • Thase ME; University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. Electronic address: thase@mail.med.upenn.edu.
  • Mahableshwarkar AR; Takeda Development Center Americas, Deerfield, IL 60015, USA.
  • Dragheim M; H. Lundbeck A/S, Copenhagen, Denmark.
  • Loft H; H. Lundbeck A/S, Copenhagen, Denmark.
  • Vieta E; Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Eur Neuropsychopharmacol ; 26(6): 979-93, 2016 06.
Article in En | MEDLINE | ID: mdl-27139079

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Sulfides / Selective Serotonin Reuptake Inhibitors / Depressive Disorder, Major Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2016 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Sulfides / Selective Serotonin Reuptake Inhibitors / Depressive Disorder, Major Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2016 Document type: Article Country of publication: